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Objective: To investigate the relationship and interaction of the single nucleotide polymorphisms (SNPs) of KLK3
and VDR and environmental factors with the predisposition to prostate cancer within Chinese population.
Methods: The comparison between 108 patients and 242 healthy people was carried out by using the TaqMan/MGB
Probe Technology to determine the genotypes of KLK3(rs2735839 is located between KLK2 and KLK3) and VDR
(rs731236 is located exon 9). Univariate and multivariate logistic regression model were used to assess the connection
of genetic polymorphisms and environmental risk factors with PCa by collecting demographic information, as well as
BMI, consumption of cigarettes, alcohol, and tea, exercise, and other environmental risk factors.
Results: The appearing frequencies of AA, AG, and GG genotypes at the SNPs rs2735839 (A/G) for KLK3 were 13.89%,
62.96% and 23.15% in PCa and 37.19%, 44.63%, 18.18% in control, respectively; these two groups are statistically
different (P = 0.00). While the appearing frequencies of TT, TC, and CC genotypes at the SNPs rs731236 (T/C) for VDR
were 88.89%, 9, 26%, 1.85% and 90.50%, 9.10%, 0.40% in control, respectively, with no significant statistical difference
between the two group. The study confirmed decreasing risk in tea drinkers (OR = 0.58, 95% CI = 0.35-0.96).
Conclusions: Our studies indicate that environmental factor-tea drinking is associated with the development of PCa.
The habit of drinking tea is a protective factor against PCa. The SNPs rs2735839 for KLK3 is strongly related to the
development of PCa, while the SNPs rs731236 for VDR is not.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
9759981571058803.
Keywords: Prostate cancer, Nucleotide polymorphisms, Environmental risk factorThe occurance of prostate cancer (PCa) in Europe and
America is higher than other area. PCa is ranked the
second most commonly occuring cancer among the
male cancer patients in Europe and American, the major
cause of male deaths in developed countries [1]. With
the aging of the population and the improvement of
living conditions in recent years, PCa incidence among
male Chinese has been increasing every year, China’s
evarage standardized incidence rate was 1.6/10 million
in 2002, while in Shanghai in 2000, the standardized
incidence rate was 7.7 / 10 million. It is estimated that
by 2010 in Shanghai, the incidence rate may be more* Correspondence: pdcuifeilun@163.com
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reproduction in any medium, provided the orthan 10/100 000 [2]. PCa is a common multifactorial,
polygenic disease with significant heterogeneity. The
mechanism of its inheritance and pathogenesis is very
complex; Environmental factors and genetic factors
jointly contribute to the occurrence of PCa. The studies
by Sonoda et al [3] suggest that environmental factors
such as diet and lifestyle, play an important role in the
pathogenesis of PCa. Loci genome-wide association
studies of multiple ethnic groups in recent years has
identified some susceptibilities associated with PCa,
however, the majority research was carried out among
African and European ethnic groups [4-6], while related
research on the Chinese population has been very limited.
The kallikrein 3 (Kallikrein 3, KLK3) gene is located on
chromosome 19q13.33, which encodes prostate specificThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Table 1 Primers and probes for genotyping of KLK3 and
VDR SNPs
Gen rs Varian Primer probe








KLK: Kallikren 3; VDR: Vitamin D receptor; SNPs: single nucleotide polymorphisms.
Table 2 Environment factors of prostate cancer
Characteristics PCa Control OR (95% CI) P
(N=108) (N=242)
Age (Year) 70.01±7.26 70.52±7.11 .73
BMI(∎m-2) 24.93±4.06 23.91±2.74 0.11
Alcohol drinking 0.04
No 56(51.85) 154(63.64) 1.00
Yes 52(48.15) 88(36.36) 1.63(1.03-2.57)
Tea n (%) 0.00
Yes 68(62.96) 180(74.38) 1.00
Smoking n (%)
Never 51(47.22) 124(51.24) 1.00
1-20 pieces/d 51(47.22) 92(38.02) 1.35(0.84-221.45)
Sports n (%) 0.39
Yes 63(58.33) 156(63.22) 1.00
No 45(41.67) 89(36.78) 1.23(0.77-1.95)
BMI body mass index.
Hu et al. Diagnostic Pathology 2014, 9:84 Page 2 of 6
http://www.diagnosticpathology.org/content/9/1/84antigen (PSA) and is a serine protease kallikrein family
member. Like other kallikrein, PCa kallikrein may be
involved the occurrence of PCa and metastasis [7,8]. The
vitamin D receptor (Vitamin D Receptor, VDR) gene is
located on chromosome 12q13.11, belonging to the steroid
hormone receptor superfamily. About the mechanism of
the VDR gene polymorphism and cancer relationship, it is
now widely recognized that 1, 25 (OH) 2D3 and its analogs
fix tumor cell growth cycle in the G1 phase via VDR,
thereby inhibiting tumor cell proliferation. VDR gene
polymorphism essentially unchanged the order of amino
acids in VDR proteins, but affects the VDR protein
expression at the transcriptional level. Change of the
VDR gene polymorphism was considered to be associated
with PCa predisposition [9] or progressive genotype [10],
but different opinions are reported [11].
It has been confirm that the single nucleotide
polymorphisms (SNPs) rs2735839 of KLK3 and the
SNPs rs731236 of VDR are associated with PCa. Seldom
research has been on the realationship of those two SNPs
and PCa occurrence within the Chinese ethic group. This
study is focused on the relationship between the KLK3
and VDR gene SNPs as well as environmental risk factors,
and the occurance of PCa within the Chinese population.
Data and methods
Patients
Clinical studies of the 108 PCa patients were carried out
from October 2007 to April 2010 at The First Affiliated
People’s Hospital of Jiangsu University. These patients
were confirmed to have PCa, with methods including B
ultrasound, CT check and pathological diagnosis. The
control group of 242 healthy people are from the
community population without any history of PCa
with normal serum PSA level.
Methods
Epidemiological investigation
Investigators developed a systematic questionnaire, and
the survey was implemented via interiews of the patients.
All the questionnaires were truthfully filled out with
the consent of the respondents. Environmental risk fac-
tors, including body mass index (BMI), comsumption
of alcohol, tea, and cigarettes, exercise, are evaluated.
BMI factor is classified into two groups: BMI ≤ 24 kg/
m2 and BMI > 24 kg/m2; regular alcohol consumption
is defined as more than once every week and contin-
ued for at least 6 months. Tea consumption: seldom
or never consumption (<4 times/week); regular tea
comsumption (≥ 4 times/week); Smoking: non-smoker,
moderate smoker (≤ 20 cigarettes/day), heavy smoker
(> 20/day); exercise: seldom exercise (<4 times/week),
regular exercise ( ≥ 4 times/week); each exercise needs to
last for as least half an hour.DNA extraction
3 ml peripheral venous blood was extracted from each
patient. After anti-coagulation by EDTA, peripheral
blood genomic DNA was extracted using the extraction
kit produced by Beijing TIANGEN, and stored at -20°C.
KLK3 and VDR genotype analysis
Primers and probes (Table 1) are desinged by Jikang
Biological Science and Technology Co., Ltd. The total
volume of the PCR reaction system is 10 μl, including
5 μl Ex TaqTM Hot Start Version (TaKaRa), 0.2 μl
primer, 0.3 μl probe, 3 μl deionized water, and 1 μl DNA
template. The reaction was carried out on a real-time
quantitative PCR instrument (LightCycle 480) and the
paramters are set as the following: 50°C for 2 min, 95°C
for 10 min, followed by 95°C for 30s and 58°C for 1 min.
40 cycles in total were performed. Fluorescence signal was
collected and automatically analyzed to identify the SNP
genotype.
Figure 1 Real-time PCR genotyping of rs2735839 (A) and rs731236 (B).
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Both laboratory testing results and epidemiological data
were entered into a computer, compared and checked to
ensure the accuracy of the entry. Hardy-Weinberg (HWE)
Genetic equilibrium analysis was carried out on the object
of the study; SPSS16.0 statistical analysis was applied:
χ2 test analysis of genotype frequencies, odds ratio
(odds ratio, OR) and 95% CI estimate on the correlation
strength of each studied factor with PCa; Logistic regression
estimates on the relationship of the independent risk
genotypes and the disease; multiplying and additive
model analysis, which sums the interaction analysis
using the relative excess risk due to interaction (RERI)
and 95% CI assessment of environmental risk factors
and genetic polymorphisms interaction. The test level (α)
was 0.05.Table 3 Two genotype frequencies of prostate cancer
between Pca and control group
SNP PCA(N=108) Controll (N=242) OR (95% CI) n%
rs2735839
AA 15(13 89) 90(37.19) 1.0 (reference)
AG 68(62.96) 108(44.63) 3.78(2.02)-7.06
GG 25(23.15) 44(18.18) 3.41(1.64-7.11)
GG+AG 93 (86.11) 152(62.81) 3.679(2.01-6.72)
rs731236
TT 96(88.89) 219(90.50) 1.0(reference)
TC 10(9.26) 22(9.10) 1.04(0.47-2.27)
CC 2(1.85) 1(0.40) 456(0.41-50.92)
CC+CT 12(11.11) 23(9.51) 1.19(0.57-2.49)
PCa: Prostate cancer; SNP: single nucleotide polymorphism; a 95%
Coincidence interval.Results
The environmental risk factors
The patients were between age 51 an 88 years, with an
average of (70.01 ± 7.26) years old; Jewett clinical stage:
32 cases, 28 cases of B stage, 32 cases of C stage,
and 48 cases of D stage; Gleason score: 4 to 7 points
for 76 cases, and 8 to 10 points for 32 cases. The age
of the control group is between 49 and 86 years, with
an average of (70.52 ± 7.11) years old. The analysis on
the environmental factor-dependance of PCa occur-
ance confirmed that alcohol consumption (48.15% vs
36.36%, P = 0.04), and tea consumption (62.96% vs
74.38%, P = 0.00); they are statistically different between
the two groups. The estimated relative risk values OR are:
1.63 [95% CI (1.03 ~ 2.57)], 0.59 [95% CI (0.36 ~ 0.95)].
The details are confirm in Table 2.
The analysis on the correlation of KLK3 and VDR genotype
and PCa
The SNPs of KLK3 and VDR, rs2735899 and rs731236,
genotyping results are confirm in Figure 1. The genotype
distribution of KLK3 and a VDR from the control group
is in Hardy-Weinberg equilibrium, and the P values are
0.25 and 0.58, respectively. As confirm in Table 3: the
differences in genotype of the SNPs of KLK3, rs2735839,
between the PCa patinets and the control groups was
statistically significant (χ2 = 19.44, P = 0.00). GG or
AG alleles, compared with AA, significantly increase
the incidence of PCa (OR = 3.67, 95% CI, 2.01 - .72);
VDR SNPs rs731236 genotype differences between the
case and control groups was not statistically significant
(χ2 = 1.65, P = 0.44).
2.2.2 The correlation between clinico-pathological
characteristics and the two SNPs. rs2735839 (KLK3 gene)
Table 4 Two SNPs and clinicopathological characteristics
in prostate cancer
Variable rs2735839 rs731236
AA AG/GG P TTg CC/CT P
Age (Year) 0.96 0.07
<70 7 44 51 3
>70 8 49 45 9
TNM classification 0.03 0.62
Localized 9 78 74 9
Aggressive 6 15 22 3
Gleason score 0.74 0.71
<7 10 66 67 9
>7 5 27 29 3
PSA ρ/ng∎ml-1 0.10 0.60
<10 2 32 31
> 13 61 65 9
PSA: Prostate specific antigen: Single nucleotide polymorphism.
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mutation distribution with age, Gleason score and PSA
level is not associated with PCa.
The frequency of SNPs rs2735839 carrying dangerous
G allele was significantly higher than in the localized
PCa than advanced PCa patients (P = 0.03), while the
difference in the frequency of SNPs rs731236 carrying
the risk allele C in localized PCa and advanced PCa
patients is not statistically significant (P = 0.66), as
confirm in Table 4.Multi-factor analysis and the interaction analysis results
Multi-factor unconditional logistic regression analysis
was carried out on potential PCa-related factors such as
consumpltion of alcohol and tea, and the genotype of
rs731236 and rs2735839. The results confirm that
tea-drinking reduces the chance of PCa occurance
(OR =0.58, 95% CI, 0.35 ~ 0.96). The genotype of
Rs2735839 is related to the occurrence of PCa (P = 0.000),
The chance of Pca occurance is 3.7 times higher for
Rs2735839 carrying AG or GG factor compared to that
carrying the AA (OR = 3.71, 95% CI = 2.02 to 6.83), as
confirm in Table 5.Table 5 Multivariate regression analysis of factors
independently associated with prostate cancer
Variable β X2 P OR(95%/CI)
Alcohol 0.42 1.185 0.276 0.85(0.64-1.14)
Tea -0.56 4.44 0.035 0.58(0.35-0.96)
rs2735839 1.28 17.80 0.000 3.71(2.02-6.83)
rs731236 0.37 0.35 0.554 1.26(0.59-2.71)
PSA: Prostate specific antigen.In order to further explore the interaction between the
relevant factors of PCa occurrence, multiplying and
additive model interaction analysis was used. The results of
the adding the interaction analysis confirms no statistically
significance of interaction between rs2735839 and tea
consumption. Although no significant interaction between
rs2735839 and tea consumption is found, within the
group that has the the polymorphism loci rs2735839
KLK3 carrying the risk genotypes GG or GA, tea drinkers
have a 55.1% reduction of the chance to have Pca, as
seen in Table 6. In the Logistic regression analysis, the
interaction term between environmental exposures-tea
consumption and the KLK3 polymorphisms (SNPs)
rs2735839 was included, and the results confirm that the
interaction is statistically significant (P = 0.037).
Discussion
So far, the etiology and pathogenesis of PCa is still elusive.
Nevertheless, the continuous development of immunology
and molecular biology methods provide the basis for the
diagnosis and prognosis of prostate cancer [12,13].
Lichtenstein et al [14] confirmed that 42% of the incidence
of PCa can be attributed to genetic factors, and the rest is
environment related. Studies on the relationship between
the KLK3 and VDR polymorphisms as well as environmen-
tal factors and PCa occurance are very limited. Recent
research on PCa whole-genome has revealed that several
SNPs on chromosome 19q13.33 are related to the increased
PCa risk [15]. The most significantly associated SNP is
rs2735839, located at the downstream 600 bp of the KLK3
gene and its encoding is KLK3, known as PSA. In an
independent research on the group genome, including PCa,
lung cancer, colon cancer, and ovarian cancer, Thomas
et al. [16] found no PCa-susceptibility on chromosome 19.
Our research has confirm that, patients with the SNP of
the KLK3 gene, rs2735839, carrying the allele GG and AG,
has a PCa risk 3.7 times higher than that carrying A
homozygotes (OR = 3.78, 95% CI = 2.03 ~~ 7.07, P = 0.00).
Xu et al. [17] reported that in terms of the chance of carry-
ing dangerous allele G in rs2735839 SNPs, of localized PCa
patients was significantly higher than of the advanced PCa
patients (P = 0.03). Gleason score growth and the risk of
gene frequencies confirmed no statistical significance,
which is consistent with our finding. Zheng et al. [18] con-
firmed based on the research on the Chinese population,
that the SNPs rs2723839 polymorphism of KLK3 related
with the risk of PCa; Kader et al. [19] confirmed that the
frequency of the rs2735839 gene and Gleason score are
statistically significant. The difference in the conclusions
may be due to genetic susceptibility and racial factors, as
well as sufficiency of the sample size.
Lundin et al. [20] first reported that vitamin D (VD)
may be associated with the causes of PCa. Cell culture
experiments confirmed that VD inhibits PCa [21]. Since
Table 6 The interaction between the polymorphism of rs2735839 and environmental risk factors with PCa
Genotype Variable Case (n=108) Control (n=242) OR 95% CI Index RERI, 95% CI
rs2735839 Tea
AA No 13 26 1.00
AA Yes 2 64 2.64 (056-12.53)
GA+GG No 55 36 13.72 (3.04-26.90) -9.20 (-25.36-6.96)
GA+GG Yes 38 116 6.16 (1.41-26.90)
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(VDR), it is speculated that PCa susceptibility may
depend on the polymorphism of the VDR genotype. The
Taq I of several SNPs in VDR is located outside the 9th
significant promoter region, which is SNPs rs731236. SNPs
rs731236 and other flag material in this chromosomal
region are stronly unbalanced; thus it is considered that this
SNPs is strongly related to PCa occurance [22]. Medeiros
[23] confirmed that in the VDR Taq I genes, rs731236
polymorphism, people who carry allele C homozygotes
only have 1/3 (OR = 0.34, 95% CI, 0.16 ~ 0.76, P <0.01) of
the risk to have PCa compared with those who carry
miscellaneous zygote or T homozygous, therefore CC
homozygotes gene is thought to prevent individual
from suffering from PCa. However Gsur et al. [24]
confirmed that within the Caucasian population in
Austria, the VDR Taq I gene polymorphism is not related
to the risk of suffering from PCa; the frequencies of the
CC genotype in PCa patients and the corresponding
controls, are 18% and 12%, respectively, and difference is
not statistically significant (OR = 1.76, 95% CI, 0.90 to
3.45, P = 0 07). Our study confirms that within the
Chinese Han population, the appearing frequencies of
the genotype TT, TC, and CC in the SNPs, rs731236
(T/C) VDR of PCa patients and the control group are
88.89%, 9.26%, 1.85% and 90.50%, 9.10%, 0.40%, (P = 0.643),
and correlation is found between rs731236 and the
occurrence PCa. Our research indicates that The
rs731236 polymorphism may not be associated with
PCa occurrence among the Chinese Han population,
combined with the previous research, it suggest that
gene polymorphism is different between different races.
Tumorigenesis is affected by both environmental and
genetic factors. Univariate analysis of the environmental
factors confirmed that alcohol consumption and tea
consumpiton are related to prostate illness, where alcohol
consumption increases the risk of suffering from PCa
while tea drinking is a protective factor. Multivariate
Logistic regression analysis confirmed that tea drinking
reduces the PCa occurance. Epidemiological studies have
pointed out that the lower occruance rate of PCa among
Asian population compared with the Westerners may be
realted to the larger conumption of tea by the former
[25,26]. The study has also found the correlation between
the occurance of PCa and tea consumtion, which may berelated to flavonols (protocatechuic) in green tea. Park
[27] confirmed that protocatechuic can reduce PCa
inplanted on mice. The analysis of environmental risk
factors and genetic factors KLK3 gene polymorphisms
(SNPs) rs2735839 revealed that multiplied interaction
exists between tea consumption and rs2735839; Tea
consumption may be against the dangerous gene GG+GA
and protect people from PCa. Further in-depth research
needs to be carry out in this aspect.
In summary, the results of this study suggest that the
occurrence of PCa is related to the genotype of KLK3
SNPs rs2735839. The SNPs rs731236 genotype of VDR
is not associated with PCa incidence. Environmental risk
factors have impact on PCa occurance. Studies show
that he expression of GOLPH3 and miR - 126 play a
positive role in the malignant progression of PCa [28,29].
The relationship between the genetic, environmental
factors and PCa incidence still need further in-depth
investigation with a largeer sample size in order to
provide a scientific basis for PCa prevention and control.
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